My Portfolio
+
LINK YOUR PORTFOLIO

Ionis Pharmaceuticals, Inc. IONS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 08/31/26 EDT
60.36quote price arrow down-0.69 (-1.13%)
Volume
1,953,949
52 week range
49.13 - 86.74
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close60.36
  • 52 Week High86.74
  • 52 Week High Date07/08/26
  • 52 Week Low49.13
  • 52 Week Low Date09/02/25

Key Stats

  • Market Cap10.031B
  • Shares Out166.18M
  • 10 Day Average Volume2.35M
  • Dividend-
  • Dividend Yield-
  • Beta0.42

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close60.36
  • 52 Week High86.74
  • 52 Week High Date07/08/26
  • 52 Week Low49.13
  • 52 Week Low Date09/02/25
  • Market Cap10.031B
  • Shares Out166.18M
  • 10 Day Average Volume2.35M
  • Dividend-
  • Dividend Yield-
  • Beta0.42

RATIOS/PROFITABILITY

  • EPS (TTM)-3.47
  • P/E (TTM)-17.39
  • Fwd P/E (NTM)-15.92
  • EBITDA (TTM)-579.49M
  • ROE (TTM)-105.50%
  • Revenue (TTM)874.089M
  • Gross Margin (TTM)98.17%
  • Net Margin (TTM)-64.66%
  • Debt To Equity (MRQ)435.17%

EVENTS

  • Earnings Date10/27/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Ionis Pharmaceuticals, Inc. develops six marketed medicines for serious diseases, including medicines for neurologic and cardiovascular diseases. Its marketed medicines consist of TRYNGOLZA, WAINUA (eplontersen), SPINRAZA (nusinersen), QALSODY (tofersen), TEGSEDI (inotersen) and WAYLIVRA (volanesorsen). TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS). WAINUA is approved for the treatment of the polyneuropathy of hereditary...
Joseph Loscalzo M.D., Ph.D.
Independent Chairman of the Board
Brett Monia Ph.D.
Chief Executive Officer, Director
Elizabeth Hougen
Chief Financial Officer, Executive Vice President - Finance
Eugene Schneider M.D.
Executive Vice President, Chief Clinical Development and Operations Officer
Patrick O'Neil Esq.
Executive Vice President, Chief Legal Officer, General Counsel and Corporate Secretary
Address
2855 Gazelle Court
Carlsbad, CA
92010
United States